BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32714988)

  • 21. Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
    Mutisya EM; Mutua G; Nyasani D; Nduta H; Kabuti RW; Muturi-Kioi V; Omosa-Manyonyi G; Abaasa A; Lindan K; Price MA; Kimani J; Anzala AO
    PLoS One; 2020; 15(8):e0238028. PubMed ID: 32834018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to participate in HIV vaccine research in a peri-urban South African community.
    Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ
    Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.
    Aliyu G; Mohammad M; Saidu A; Mondal P; Charurat M; Abimiku A; Nasidi A; Blattner W
    AIDS Care; 2010 Oct; 22(10):1277-84. PubMed ID: 20661789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda.
    Kiwanuka N; Robb M; Kigozi G; Birx D; Philips J; Wabwire-Mangen F; Wawer MJ; Nalugoda F; Sewankambo NK; Serwadda D; Gray RH
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):721-5. PubMed ID: 15167291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/II HIVIS 03 trial.
    Bakari M; Munseri P; Francis J; Aris E; Moshiro C; Siyame D; Janabi M; Ngatoluwa M; Aboud S; Lyamuya E; Sandström E; Mhalu F
    BMC Public Health; 2013 Dec; 13():1149. PubMed ID: 24321091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China.
    Dong Y; Shen X; Guo R; Liu B; Zhu L; Wang J; Zhang L; Sun J; Zhang X; Xu J
    PLoS One; 2014; 9(11):e111321. PubMed ID: 25372044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda.
    Ruzagira E; Wandiembe S; Bufumbo L; Levin J; Price MA; Grosskurth H; Kamali A
    Trop Med Int Health; 2009 Feb; 14(2):196-203. PubMed ID: 19207177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
    Nyasani DK; Mutua GN; Sajabi RM; Ng'ang'a JW; Gachie JN; Maina AM; Lusike LL; Anzala AO; Price MA; Manyonyi GO
    PLoS One; 2018; 13(11):e0206656. PubMed ID: 30388145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praça Onze Study Group.
    Périssé AR; Schechter M; Moreira RI; do Lago RF; Santoro-Lopes G; Harrison LH
    J Acquir Immune Defic Syndr; 2000 Dec; 25(5):459-63. PubMed ID: 11141246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.
    Tarimo EA; Thorson A; Kohi TW; Mwami J; Bakari M; Sandström E; Kulane A
    BMC Public Health; 2010 May; 10():292. PubMed ID: 20509908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of HIV vaccine trial participation: an Indian perspective.
    Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
    Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda.
    Kiwanuka N; Ssetaala A; Mpendo J; Wambuzi M; Nanvubya A; Sigirenda S; Nalutaaya A; Kato P; Nielsen L; Kaleebu P; Nalusiba J; Sewankambo NK
    J Int AIDS Soc; 2013 Jul; 16(1):18621. PubMed ID: 23880102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military.
    McGrath JW; George K; Svilar G; Ihler E; Mafigiri D; Kabugo M; Mugisha E
    J Acquir Immune Defic Syndr; 2001 Aug; 27(4):381-8. PubMed ID: 11468427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knowledge of HIV/AIDS and preventive measures use by city commuter-bus drivers and conductors in Dar Es Salaam, Tanzania.
    Mugoyelaand V; Charles V
    East Afr J Public Health; 2009 Apr; 6(1):73-6. PubMed ID: 20000069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in HIV risk behaviors by gender in a sample of Tanzanian injection drug users.
    Williams ML; McCurdy SA; Atkinson JS; Kilonzo GP; Leshabari MT; Ross MW
    AIDS Behav; 2007 Jan; 11(1):137-44. PubMed ID: 17004117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sexual behavior and condom use in female students in Dar-es-Salaam, Tanzania: differences by steady and casual partners.
    Maswanya ES; Moji K; Aoyagi K; Takemoto T
    East Afr J Public Health; 2011 Jun; 8(2):69-76. PubMed ID: 22066289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: a potential population for HIV vaccine trials.
    Bakari M; Lyamuya E; Mugusi F; Aris E; Chale S; Magao P; Jossiah R; Janabi M; Swai A; Pallangyo N; Sandström E; Mhalu F; Biberfeld G; Pallangyo K
    AIDS; 2000 Feb; 14(3):313-20. PubMed ID: 10716508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of high-risk sexual behaviour and condom use among adults in the Arusha region, Tanzania.
    Mnyika KS; Klepp KI; Kvåle G; Ole-Kingóri N
    Int J STD AIDS; 1997 Mar; 8(3):176-83. PubMed ID: 9089028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials.
    Jaspan HB; Berwick JR; Myer L; Mathews C; Flisher AJ; Wood R; Bekker LG
    J Adolesc Health; 2006 Nov; 39(5):642-8. PubMed ID: 17046499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania.
    Tarimo EA; Thorson A; Kohi TW; Bakari M; Mhalu F; Kulane A
    PLoS One; 2011 Feb; 6(2):e14619. PubMed ID: 21358826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.